Precigen (PGEN) Goodwill & Intangibles (2012 - 2026)
Precigen (PGEN) posted quarterly Goodwill & Intangibles of $18.1 million for Q1 2026, down 22.25% year-over-year from $23.3 million in Q1 2025, and down 1.73% quarter-over-quarter from $18.4 million in Q4 2025.
Analysis
Precigen (PGEN) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Goodwill & Intangibles for 15 consecutive years, with $18.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 22.25% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (down 22.25% YoY), while the FY2025 annual figure was $18.4 million, down 21.95% from the prior year.
- Goodwill & Intangibles slipped to $18.1 million in Q1 2026 per PGEN's latest filing, from $18.4 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $105.0 million in Q1 2022 and bottomed at $18.1 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $52.9 million across 5 years, with a median of $65.3 million in 2024.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles fell 2.29% — and 2024, when it sank 64.95%.
- Precigen's Goodwill & Intangibles stood at $81.4 million in 2022, then dropped by 17.28% to $67.3 million in 2023, then tumbled by 64.95% to $23.6 million in 2024, then slipped by 21.95% to $18.4 million in 2025, then slipped by 1.73% to $18.1 million in 2026.
- Business Quant data shows PGEN's Goodwill & Intangibles at $18.1 million in Q1 2026, $18.4 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.78 Mn |
| Mar 31, 2026 | 18.10 Mn |
| Dec 31, 2025 | 18.41 Mn |
| Sep 30, 2025 | 18.73 Mn |
| Jun 30, 2025 | 19.05 Mn |
| Mar 31, 2025 | 23.28 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 29.69 Mn |
| Jun 30, 2024 | 30.01 Mn |
| Mar 31, 2024 | 65.27 Mn |
| Dec 31, 2023 | 67.31 Mn |
| Sep 30, 2023 | 77.32 Mn |
| Jun 30, 2023 | 79.62 Mn |
| Mar 31, 2023 | 80.81 Mn |
| Dec 31, 2022 | 81.38 Mn |
| Sep 30, 2022 | 79.13 Mn |
| Jun 30, 2022 | 82.80 Mn |
| Mar 31, 2022 | 105.04 Mn |
| Dec 31, 2021 | 89.85 Mn |
| Sep 30, 2021 | 111.12 Mn |